[B-cell-depleting antibodies in skin diseases].
Basic insight into immune mechanisms, particularly the role and function of various immune cells and proinflammatory cytokines in the etiopathogenesis of inflammatory dermatoses and autoimmune skin disorders, has made possible the development of novel therapeutic strategies. Because of their properties as antigen presenting cells and progenitors of autoantibody-secreting plasma cells, B cells have a major impact in different autoimmune diseases and represent an important therapeutic target. The remarkable clinical improvement seen in patients with rheumatoid arthritis after treatment with the monoclonal anti-CD20 antibody, rituximab, has strongly augmented the interest in B-cell-targeted therapies in different autoimmune diseases. Future clinical and immunological investigations are mandatory to precisely define the contribution of impaired B-cell function in development and progression of autoimmune mediated skin disorders.
Nagel
A
A
Klinik für Dermatologie and Allergologie, Philipps Universität Marburg, Deutschhausstrasse 9, 35037, Marburg, Deutschland.
Hertl
M
M
Eming
R
R
D000906:Antibodies / Q000276:immunology*; D001402:B-Lymphocytes / Q000276:immunology*; D006801:Humans; D018448:Models, Immunological; D012871:Skin Diseases / Q000276:immunology* / Q000473:pathology*
D000906:Antibodies
J Invest Dermatol. 2008 Dec;128(12):2850-8
18563178
Arthritis Res Ther. 2006;8(6):R167
17092341
J Allergy Clin Immunol. 2003 Apr;111(4):697-703
12704346
Arthritis Rheum. 2007 May;56(5):1464-77
17469105
J Exp Med. 2005 Mar 7;201(5):703-11
15738055
Immunity. 2004 May;20(5):517-27
15142521
J Exp Med. 1996 Mar 1;183(3):717-9
8642274
Eur J Immunol. 2002 Mar;32(3):627-33
11857336
Blood. 2008 Aug 15;112(4):1147-50
18375792
Nat Rev Drug Discov. 2006 Jul;5(7):564-76
16816838
N Engl J Med. 2006 Oct 26;355(17):1772-9
17065638
Clin Immunol. 2007 Jan;122(1):62-74
17046329
Ann Rheum Dis. 2007 Jun;66(6):818-20
17148544
Ann Rheum Dis. 2007 Mar;66(3):351-7
16950808
J Clin Invest. 2005 Nov;115(11):3083-92
16239971
J Dtsch Dermatol Ges. 2008 May;6(5):366-73
18201220
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20878-83
18093919
Br J Dermatol. 2006 Aug;155(2):330-6
16882171
Eur J Immunol. 2008 Jan;38(1):292-8
18085668
N Engl J Med. 2007 Aug 9;357(6):545-52
17687130
J Clin Invest. 2006 May;116(5):1159-66
16670756
Ann N Y Acad Sci. 2005 Jun;1050:34-9
16014518
Br J Dermatol. 2005 Sep;153(3):620-5
16120153
Ann Rheum Dis. 2008 Jul;67(7):917-25
17965121
Arthritis Rheum. 2007 Mar;56(3):772-8
17328049
Arthritis Rheum. 2006 Jan;54(1):192-201
16385515
Curr Opin Immunol. 2007 Jun;19(3):327-36
17433868
Immunity. 2004 Jun;20(6):785-98
15189742
J Allergy Clin Immunol. 2008 Jan;121(1):122-8
18206507
J Invest Dermatol. 2006 Dec;126(12):2621-30
16841036
Arthritis Rheum. 2006 Feb;54(2):613-20
16447239
J Immunol. 2005 Jan 15;174(2):817-26
15634903
Exp Dermatol. 2007 Feb;16(2):87-93
17222220
Arthritis Res Ther. 2006;8(4):R129
16859536
Arthritis Rheum. 2006 Aug;54(8):2377-86
16869000
Clin Immunol. 2007 Apr;123(1):66-73
17275413